William D. Turner
Corporate Officer/Principal at VERA THERAPEUTICS, INC.
Profile
William D.
Turner is currently the Chief Development Officer at Vera Therapeutics, Inc. Prior to his current position, he held the role of Senior Director-Regulatory Affairs at MedImmune Vaccines, Inc. and Medimmune, Inc. He also served as the Vice President-Regulatory Affairs at Dynavax Technologies Corp.
from 2006 to 2009.
From 2020 to 2022, he was the Chief Regulatory & Technical Operations Officer at Sierra Oncology, Inc. Before that, he worked as the SVP-Technical Operations & Regulatory at Aimmune Therapeutics, Inc. from 2018 to 2020.
Mr. Turner completed his undergraduate degree at The California State University.
William D. Turner active positions
| Companies | Position | Start |
|---|---|---|
| VERA THERAPEUTICS, INC. | Corporate Officer/Principal | 08/01/2023 |
Former positions of William D. Turner
| Companies | Position | End |
|---|---|---|
| SIERRA ONCOLOGY, INC. | Chief Tech/Sci/R&D Officer | 01/07/2022 |
| AIMMUNE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/04/2020 |
| Medimmune, Inc. | General Counsel | - |
MedImmune Vaccines, Inc.
 MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | General Counsel | - |
| DYNAVAX TECHNOLOGIES CORPORATION | General Counsel | - |
Training of William D. Turner
| The California State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
| VERA THERAPEUTICS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Health Technology |
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Sierra Oncology, Inc. was a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focused on advanced targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded in May 2003 and is headquartered in San Mateo, CA. | Health Technology |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
| Medimmune, Inc. | Health Technology |
- Stock Market
- Insiders
- William D. Turner